TABLE 1.
Cohort demographic data
| COVID‐(M) | COVID‐(F) | COVID + (M) | COVID + (F) | Hospitalized (M) | Hospitalized (F) | Long‐COVID (M) | Long‐COVID (F) | |
|---|---|---|---|---|---|---|---|---|
| Total | 261,002 (44.6%) | 323,778 (55.4%) | 14,685 (43.5%) | 19,089 (56.5%) | 694 (55.6%) | 554 (44.4%) | 154 (35.4%) | 281 (64.6%) |
| Median age [min:max] | 52 [18:100] | 47 [18:99] | 46 [18:98] | 42 [18:99] | 63 [22:94] | 54 [20:95] | 50.5 [21:75] | 48 [19:79] |
| ABO (A) | 109,086 (41.8%) | 133,932 (41.4%) | 6620 (45.1%) | 8393 (44%) | 336 (48.4%) | 243 (43.9%) | 61 (39.6%) | 123 (43.8%) |
| ABO (AB) | 12,470 (4.8%) | 15,838 (4.9%) | 763 (5.2%) | 1003 (5.3%) | 46 (6.6%) | 43 (7.8%) | 8 (5.2%) | 16 (5.7%) |
| ABO (B) | 28,787 (11%) | 36,651 (11.3%) | 1621 (11%) | 2180 (11.4%) | 65 (9.4%) | 57 (10.3%) | 17 (11%) | 26 (9.3%) |
| ABO (O) | 110,659 (42.4%) | 137,357 (42.4%) | 5681 (38.7%) | 7513 (39.4%) | 247 (35.6%) | 211 (38.1%) | 68 (44.2%) | 116 (41.3%) |
| Lewis (Lea‐) | 39,649 (80.8%) | 40,313 (81.2%) | 1563 (83.0%) | 1681 (83.5%) | 99 (82.5%) | 62 (80.5%) | 19 | 24 (77.4%) |
| Lewis (Lea+) | 9429 (19.2%) | 9357 (18.8%) | 320 (17.0%) | 331 (16.5%) | 21 (17.5%) | 15 (19.5%) | <5 | 7 (22.6%) |
| Lewis (Leb‐) | 9212 (26.8%) | 8208 (26.8%) | 303 (25.1%) | 299 (27.0%) | 26 (23.6%) | 16 (26.2%) | <5 | 8 (32.0%) |
| Lewis (Leb+) | 25,217 (73.2%) | 22,413 (73.2%) | 904 (74.9%) | 807 (73.0%) | 84 (76.4%) | 45 (73.8%) | 16 | 17 (68.0%) |
| Rh (D‐) | 45,923 (17.6%) | 62,978 (19.4%) | 2597 (17.7%) | 3578 (18.7%) | 131 (18.9%) | 106 (19.1%) | 29 (18.8%) | 50 (17.8%) |
| Rh (D+) | 215,216 (82.4%) | 260,984 (80.6%) | 12,086 (82.3%) | 15,515 (81.3%) | 563 (81.1%) | 448 (80.9%) | 125 (81.2%) | 231 (82.2%) |
| Secretor (Se‐) | 9177 (20.0%) | 9045 (19.8%) | 561 (19.5%) | 571 (19.4%) | 20 (25.6%) | 13 (23.6%) | 20 (18.5%) | 44 (22.6%) |
| Secretor (Se+) | 36,782 (80.0%) | 36,668 (80.2%) | 2314 (80.5%) | 2376 (80.6%) | 58 (74.4%) | 42 (76.4%) | 88 (81.5%) | 151 (77.4%) |
Note: Demographic stats for the 618,554 donors in the cohort. Blood group is named first, then the antigen in question, and lastly positive (+) or negative (−) status for each antigen. Males (M) and females (F) have separate columns, as does COVID‐19 status (COVID+/COVID−), COVID‐19‐related hospitalization (hospitalized), and long COVID‐19 symptoms (long COVID‐19).